Capricor Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

캐프리코 테라퓨틱스NASDAQ:CAPR · Nasdaq · Healthcare

$8.95+0.11%

2026-10-02 close

Capricor Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $22M. 2024 operating profit was −$43M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy